2003
DOI: 10.1002/mrd.10265
|View full text |Cite
|
Sign up to set email alerts
|

Effect of roscovitine, a cdk1 inhibitor, and of the presence of oocyte on bovine cumulus cell expansion and cyclooxygenase‐2 expression

Abstract: Oocyte maturation is accompanied by differentiation of surrounding cumulus cells. These cells produce hyaluronic acid (HA) and its storage in intercellular spaces results in expansion of the cells. The cumulus cells also accumulate cyclooxygenase-2 (cox-2) during maturation. Both expansion and cox-2 storage are regulated by FSH and EGF. The aim of this study was to determine whether oocyte meiotic resumption is involved in the regulation of cumulus differentiation or not. We investigated the effects of roscovi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
11
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 55 publications
1
11
0
Order By: Relevance
“…The disparity in the dose of roscovitine utilized by others (Mermillod et al 2000, Calder et al 2001, Duque et al 2002, Lagutina et al 2002, Vigneron et al 2003 versus that required in our study may be due to differences in roscovitine activity related to source, use of a different enantiomer, differences in the composition of the roscovitine medium or other unidentified factors. Dr Laurent Meijer has provided the roscovitine used in the majority of available studies (Mermillod et al 2000, Lagutina et al 2002, Lonergan et al 2003, Vigneron et al 2003. In contrast, we utilized a commercial source of the (S)-enantiomer.…”
Section: Discussionmentioning
confidence: 62%
See 1 more Smart Citation
“…The disparity in the dose of roscovitine utilized by others (Mermillod et al 2000, Calder et al 2001, Duque et al 2002, Lagutina et al 2002, Vigneron et al 2003 versus that required in our study may be due to differences in roscovitine activity related to source, use of a different enantiomer, differences in the composition of the roscovitine medium or other unidentified factors. Dr Laurent Meijer has provided the roscovitine used in the majority of available studies (Mermillod et al 2000, Lagutina et al 2002, Lonergan et al 2003, Vigneron et al 2003. In contrast, we utilized a commercial source of the (S)-enantiomer.…”
Section: Discussionmentioning
confidence: 62%
“…Numerous studies have described the effectiveness of the R-enantiomer of roscovitine to meiotically inhibit bovine oocytes (Mermillod et al 2000, Kasinathan et al 2001, Lagutina et al 2002, Vigneron et al 2003. However, reported differences in the potency of the R-versus the S-enantiomer of roscovitine to inhibit p34 cdc2 kinase activity (De Azevedo et al 1997, reviewed by Meijer & Raymond 2003 along with recent unpublished observations (L Meijer, unpublished observations) showing increased selectivity towards other protein kinases, warrant further investigation of the S-enantiomer of roscovitine.…”
Section: Discussionmentioning
confidence: 99%
“…The 20a-HSD enzyme catalyzes the conversion of progesterone into its inactive form, 20a-hydroxyprogesterone. We used a wellestablished model for in vitro maturation (IVM) inducing differential levels of oocyte maturation, cumulus expansion, and PTGS2 expression (Nuttinck et al 2002, Vigneron et al 2003. Differential expression of the studied enzymes was analyzed in relation to the rate of in vitro fertilization (IVF) and subsequent embryo development.…”
Section: Introductionmentioning
confidence: 99%
“…Enhanced cumulus expansion due to EGF stimulation in bovine COCs is blocked by roscovitine, an inhibitor of maturation/M-phase promoting factor (MPF) kinase activity (Vigneron et al 2003) and the tyrosine kinase activity of the EGF receptor (EGFR) is required for EGF-stimulated expansion in pig COCs (Prochazka et al 2003). Based on its ability to directly enhance cytoplasmic maturation in mouse and human oocytes (Das et al 1991), inclusion of EGF in in vitro fertilization (IVF) procedures may serve to improve success.…”
Section: Introductionmentioning
confidence: 99%